- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Daratumumab and Hyaluronidase-fihj
Total 426 results
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCCompleted
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); Stem Cell NetworkActive, not recruitingAnterior Wall Myocardial InfarctionCanada
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular... and other conditionsUnited States
-
Sumithira VasuCompletedRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes | Recurrent Adult Acute Myeloid Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Minimal Residual DiseaseUnited States
-
Halozyme TherapeuticsCompleted
-
National University Hospital, SingaporeJanssen, LP; International Myeloma FoundationUnknownRelapse and / or Refractory MyelomaSingapore, Hong Kong, Taiwan, Korea, Republic of
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type 2United States
-
Second Affiliated Hospital of Soochow UniversityThe Affiliated Hospital of Xuzhou Medical UniversityRecruitingRelapsed/Refractory Multiple MyelomaChina
-
H. Lee Moffitt Cancer Center and Research InstituteJanssen Scientific Affairs, LLCActive, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
Baxalta now part of ShireCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMyocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease
-
TakedaTakeda Development Center Americas, Inc.Not yet recruitingPrimary Immunodeficiency Diseases (PID)
-
TakedaTakeda Development Center Americas, Inc.; Baxalta Innovations GmbH, now part...Completed
-
Syros PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States, France
-
University Hospital, LilleJanssen Pharmaceutica N.V., BelgiumNot yet recruiting
-
Emory UniversityGenentech, Inc.Active, not recruitingStage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Unresectable Melanoma | Stage III Melanoma | Stage IIIA Skin Melanoma | Cutaneous Melanoma, Stage III | Cutaneous Melanoma, Stage IVUnited States
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompleted
-
Baxter Healthcare CorporationHalozyme TherapeuticsCompleted
-
Hacettepe UniversityCompletedPain | Edema | Trismus | Infection, Surgical SiteCyprus, Turkey
-
ShireHalozyme TherapeuticsCompletedHereditary AngioedemaUnited States
-
ShireCompletedHereditary Angioedema (HAE)United States, Germany, Spain, Sweden
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type 1United States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedVarious Advanced CancerUnited States, Belgium, France, Germany, Japan, Korea, Republic of, Mexico, Netherlands, Spain, Taiwan, United Kingdom
-
Halozyme TherapeuticsCompletedType 1 Diabetes MellitusUnited States
-
Human Genome Sciences Inc.CompletedMultiple MyelomaUnited States, Canada, Australia, India
-
Fondazione Italiana Linfomi - ETSJanssen-Cilag S.p.A.RecruitingPlasmablastic LymphomaItaly
-
Halozyme TherapeuticsCompletedType 1 Diabetes MellitusUnited States
-
The First Affiliated Hospital of Soochow UniversityNot yet recruiting
-
Nektar TherapeuticsCompletedMultiple Myeloma | Non-Hodgkin Lymphoma | Indolent Non-Hodgkin LymphomaUnited States
-
HPC Healthcare, Inc.Baxter Healthcare CorporationCompleted
-
PETHEMA FoundationJanssen PharmaceuticaRecruitingHigh-Risk de Novo Multiple MyelomaSpain
-
Mayo ClinicRecruitingAL AmyloidosisUnited States
-
Alliance Foundation Trials, LLC.Takeda; Janssen Scientific Affairs, LLC; Celgene CorporationActive, not recruitingMyeloma, MultipleUnited States
-
Hoffmann-La RocheCompleted
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)RecruitingRecurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Indolent Adult Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Indolent Adult Non-Hodgkin...United States
-
ViiV HealthcareRecruiting
-
Scripps HealthTerminatedPancreatic Adenocarcinoma Non-resectableUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruitingMultiple MyelomaUnited States
-
Halozyme TherapeuticsCompletedStage IV Pancreatic CancerUnited States, Russian Federation
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Alfred Chung, MDAbbVie; Janssen PharmaceuticalsRecruitingAL Amyloidosis | Light Chain (AL) Amyloidosis | Systemic Light Chain DiseaseUnited States
-
University Hospital, LilleActive, not recruiting
-
TakedaActive, not recruitingMultiple MyelomaUnited States, Spain, Belgium, Israel
-
University of Wisconsin, MadisonWithdrawn
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type 1United States
-
Halozyme TherapeuticsCompleted
-
Weill Medical College of Cornell UniversityJanssen Scientific Affairs, LLCRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedCarcinoma, HepatocellularPuerto Rico, United States, Germany, Ukraine, Russian Federation, Poland, Romania
-
University of Alabama at BirminghamRecruitingMultiple MyelomaUnited States